Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  813 results for "double-blind method"

Your Filters

Publication : respiratory research
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

ARTEMISIA: a mechanistic study of a novel Janus kinase 1 inhibitor to advance molecular understanding and precision medicine in asthma.

  • Authors : Dosanjh DPS; Clinical Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. .; Birmingham Acute Care Research, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK. .

Subjects: Artemisia* ; Asthma*/Asthma*/Asthma*/drug therapy ; Asthma*/Asthma*/Asthma*/enzymology

  • Source: Respiratory research [Respir Res] 2025 Jul 02; Vol. 26 (1), pp. 233. Date of Electronic Publication: 2025 Jul 02.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β 2 -agonist: post-hoc analyses of KRONOS.

  • Authors : Singh D; Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester, M23 9QZ, UK. .; Bafadhel M

Subjects: Adrenal Cortex Hormones*/Adrenal Cortex Hormones*/Adrenal Cortex Hormones*/administration & dosage ; Adrenergic beta-2 Receptor Agonists*/Adrenergic beta-2 Receptor Agonists*/Adrenergic beta-2 Receptor Agonists*/administration & dosage ; Bronchodilator Agents*/Bronchodilator Agents*/Bronchodilator Agents*/administration & dosage

  • Source: Respiratory research [Respir Res] 2025 May 08; Vol. 26 (1), pp. 175. Date of Electronic Publication: 2025 May 08.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Low dose of morphine to relieve dyspnea in acute respiratory failure: the OpiDys double-blind randomized controlled trial

Subjects: Male; Adult; RC705-779

  • Source: Respir ResRespiratory Research, Vol 25, Iss 1, Pp 1-12 (2024)

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial.

  • Authors : Park HJ; Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.; Kim SH

Subjects: Quality of Life*; Antigens, Dermatophagoides/Antigens, Dermatophagoides/Antigens, Dermatophagoides/*administration & dosage ; Desensitization, Immunologic/Desensitization, Immunologic/Desensitization, Immunologic/*methods

  • Source: Respiratory research [Respir Res] 2021 Jun 04; Vol. 22 (1), pp. 170. Date of Electronic Publication: 2021 Jun 04.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Effects of the Toll-like receptor 7 (TLR7) agonist, AZD8848, on allergen-induced responses in patients with mild asthma: a double-blind, randomised, parallel-group study.

  • Authors : Leaker BR; Respiratory Clinical Trials Ltd, Queen Anne Street Medical Centre, 18-22 Queen Anne Street, London, W1G 8HU, UK. .; Singh D

Subjects: Adenosine/Adenosine/Adenosine/*analogs & derivatives ; Allergens/Allergens/Allergens/*adverse effects ; Anti-Asthmatic Agents/Anti-Asthmatic Agents/Anti-Asthmatic Agents/*administration & dosage

  • Source: Respiratory research [Respir Res] 2019 Dec 19; Vol. 20 (1), pp. 288. Date of Electronic Publication: 2019 Dec 19.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

The longitudinal impact of low-dose morphine on diurnal cortisol profiles in people with chronic breathlessness and chronic obstructive pulmonary disease (COPD): an exploratory study.

  • Authors : Ferreira DH; Graduate School of Medicine, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW, Australia.; Ryan R

Subjects: Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/drug therapy ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/metabolism ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/diagnosis

  • Source: Respiratory research [Respir Res] 2025 Apr 23; Vol. 26 (1), pp. 156. Date of Electronic Publication: 2025 Apr 23.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma

Subjects: Adult; Male; Severe asthma

  • Source: Respir ResRespiratory Research, Vol 21, Iss 1, Pp 1-10 (2020)

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Hydrogen/oxygen therapy for the treatment of an acute exacerbation of chronic obstructive pulmonary disease: results of a multicenter, randomized, double-blind, parallel-group controlled trial

Subjects: Male; China; Time Factors

  • Source: Respir ResRespiratory Research, Vol 22, Iss 1, Pp 1-12 (2021)

Record details

Read Online Read More Add to Saved list
×
Academic Journal

SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma

Subjects: Adult; Male; 0301 basic medicine

  • Source: Respir ResRespiratory Research, Vol 21, Iss 1, Pp 1-10 (2020)

Record details

Read Online Read More Add to Saved list
×
Academic Journal

NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma

Subjects: Adult; Aged, 80 and over; Male

  • Source: Respir ResRespiratory Research, Vol 21, Iss 1, Pp 1-12 (2020)

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  813 results for "double-blind method"